drugset / Trial / NCT03769064
Study for Naltrexone on the Abuse Potential of Methylphenidate
RandomizedCrossoverTriple-blindTreatment
Summary
The current abuse liability study aims to assess the potential for co-administration of naltrexone (NTX) to reduce the abuse potential of methylphenidate (MPH).
Timeline
- Start
- 2018-03-27
- Primary completion
- 2018-06-20
- Completion
- 2018-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 60 mg | — |
| Subject | Naltrexone | Small molecule | 50 mg | — |
| Subject | Naltrexone | Small molecule | 100 mg | — |